MicroRNA related polymorphisms and breast cancer risk

• Main Authors: Khan S., Greco D., Michailidou K., Milne R.L., Muranen T.A., Heikkinen T., Aaltonen K., Dennis J., Bolla M.K., Liu J., Hall P., Irwanto A., Humphreys K., Li J., Czene K., Chang-Claude J., Hein R., Rudolph A., Seibold P., Flesch-Janys D., Fletcher O., Peto J., Silva I.D.S., Johnson N., Gibson L., Aitken Z., Hopper J.L., Tsimiklis H., Bui M., Makalic E., Schmidt D.F., Southey M.C., Apicella C., Stone J., Waisfisz Q., Meijers-Heijboer H., Adank M.A., Van Der Luijt R.B., Meindl A., Schmutzler R.K., Müller-Myhsok B., Lichtner P., Turnbull C., Rahman N., Chanock S.J., Hunter D.J., Cox A., Cross S.S., Reed M.W.R., Schmidt M.K., Broeks A., Van'T Veer L.J., Hogervorst F.B., Fasching P.A., Schrauder M.G., Ekici A.B., Beckmann M.W., Bojesen S.E., Nordestgaard B.G., Nielsen S.F., Flyger H., Benitez J., Zamora P.M., Perez J.I.A., Haiman C.A., Henderson B.E., Schumacher F., March L.L., Pharoah P.D.P., Dunning A.M., Shah M., Luben R., Brown J., Couch F.J., Wang X., Vachon C., Olson J.E., Lambrechts D., Moisse M., Paridaens R., Christiaens M.-R., Guénel P., Truong T., Laurent-Puig P., Mulot C., Marme F., Burwinkel B., Schneeweiss A., Sohn C., Sawyer E.J., Tomlinson I., Kerin M.J., Miller N., Andrulis I.L., Knight J.A., Tchatchou S., Mulligan A.M., Dörk T., Bogdanova N.V., Antonenkova N.N., Anton-Culver H., Darabi H., Eriksson M., Garcia-Closas M., Figueroa J., Lissowska J., Brinton L., Devilee P., Tollenaar R.A.E.M., Seynaeve C., Van Asperen C.J., Kristensen V.N., Australian Ovarian Cancer Study Group S.S., Tol A.E., Ambrosone C.B., Yannoukakos D., Lindblom A., Margolin S., Radice P., Peterlongo P., Barile M., Mariani P., Hooning M.J., Martens J.W.M., Margriet Collée J., Jager A., Jakubowska A., Lubinski J., Jaworska-Bieniek K., Durda K., Giles G.G., McLean C., Brauch H., Brüning T., Ko Y.-D., The Genica Network H.B., Dieffenbach A.K., Arndt V., Stegmaier C., Swerdlow A., Ashworth A., Orr N., Jones M., Simard J., Goldberg M.S., Labrèche F., Dumont M., Winqvist R., Pylkäs K., Jukkola-Vuorinen A., Grip M., Kataja V., Kosma V.-M., Hartikainen J.M., Mannermaa A., Hamann U., Chenevix-Trench G., Blomqvist C., Aittomäki K., Easton D.F., Nevanlinna H.
• Other Authors: SURGERY
• Format: Article
• Published: 2019
• Subjects: caspase 8; microRNA; 3' untranslated region; estrogen receptor; adult; allele; apoptosis; Article; binding site; breast cancer; cancer risk; cancer susceptibility; CASP8 gene; controlled study; disease association; DROSHA gene; estrogen receptor positive breast cancer; ethnic group; female; gene; gene expression regulation; gene function; genetic association; genotype; HDDC3 gene; human; major clinical study; MUSTN1 gene; MYCL1 gene; RNA processing; single nucleotide polymorphism; biology; Breast Neoplasms; case control study; chromosome map; genetics; metabolism; 3' Untranslated Regions; Binding Sites; Case-Control Studies; Chromosome Mapping; Computational Biology; Female; Genome-Wide Association Study; Genotype; Humans; MicroRNAs; Polymorphism, Single Nucleotide; Receptors, Estrogen
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/161759
• Institution: National University of Singapore

10.1371/journal.pone.0109973